(Q46926372)

26 December 2017

title

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study (English)

1 reference

26 December 2017

0 references

1 reference

1 reference

1 reference

1

H Yki-Järvinen

1 reference

26 December 2017

R Kauppinen-Mäkelin

2

1 reference

26 December 2017

M Tiikkainen

3

1 reference

26 December 2017

M Vähätalo

4

1 reference

26 December 2017

H Virtamo

5

1 reference

26 December 2017

K Nikkilä

6

1 reference

26 December 2017

T Tulokas

7

1 reference

26 December 2017

S Hulme

8

1 reference

26 December 2017

K Hardy

9

1 reference

26 December 2017

S McNulty

10

1 reference

26 December 2017

J Hänninen

11

1 reference

26 December 2017

H Levänen

12

1 reference

26 December 2017

S Lahdenperä

13

1 reference

26 December 2017

R Lehtonen

14

1 reference

26 December 2017

L Ryysy

15

1 reference

26 December 2017

publication date

3 February 2006

1 reference

26 December 2017

published in

Diabetologia

1 reference

26 December 2017

volume

49

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

442-451

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s00125-005-0132-0

exact match

0 references

cites work

Insulin plus a Sulfonylurea Agent for Treating Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-0132-0

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-0132-0

Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-0132-0

Minimization: A new method of assigning patients to treatment and control groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-0132-0

Combination of insulin and metformin in the treatment of type 2 diabetes

21 January 2018

1 reference

12 December 2020

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

1 reference

12 December 2020

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

1 reference

12 December 2020

Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDM.

1 reference

12 December 2020

Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk

1 reference

12 December 2020

Stimulation of counterregulatory hormonal responses in diabetic man by a fall in glucose concentration

1 reference

12 December 2020

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

12 December 2020

Contribution of impaired muscle glucose clearance to reduced postabsorptive systemic glucose clearance in NIDDM.

1 reference

12 December 2020

Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM.

1 reference

12 December 2020

Determination of free and total insulin and C-peptide in insulin-treated diabetics

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

1 reference

12 December 2020

Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy

1 reference

12 December 2020

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

12 December 2020

Combination therapies with insulin in type 2 diabetes

1 reference

12 December 2020

Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients

1 reference

12 December 2020

Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis

1 reference

12 December 2020

Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease

1 reference

12 December 2020

Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

1 reference

12 December 2020

Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus

1 reference

12 December 2020

Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

10.1007/S00125-005-0132-0

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

16456680

1 reference

26 December 2017